Preventive blood thinning drugs linked to reduced risk of death in COVID-19 patients

0

Preventive blood thinning drugs linked to reduced risk of death in COVID-19 patients

Patients given preventive blood thinning drugs (prophylactic anticoagulants) within 24 hours of admission to hospital with COVID-19 are less likely to die compared with those who do not receive them, finds a study published by The BMJ today.

Comments are closed.

New study gives hope of eliminating mother-to-baby transmission of HIV
11 February 2021
Tuning the circadian clock, boosting rhythms may be key to future treatments and medicines
12 February 2021